Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 5 Component(s), Includes Credits Includes a Live Web Event on 12/06/2022 at 2:00 PM (EST)

    This webinar will address how AIA proceedings impact Life Sciences patents. A review of PTAB statistics pertaining to Life Sciences patents will be provided and compared against other industries. The panel will discuss the impact of AIA proceedings on parallel Hatch Waxman litigation and BPCIA litigation. Speakers will also discuss the advantages and disadvantages of AIA proceedings, and debate ways that the proceedings could be improved to address industry concerns.

    This webinar will address how AIA proceedings impact Life Sciences patents. A review of PTAB statistics pertaining to Life Sciences patents will be provided and compared against other industries. The panel will discuss the impact of AIA proceedings on parallel Hatch Waxman litigation and BPCIA litigation. Speakers will also discuss the advantages and disadvantages of AIA proceedings, and debate ways that the proceedings could be improved to address industry concerns.

    Ashita Doshi

    IP Counsel Leader for IP Disputes

    Thermo Fisher Scientific

    Ashita Doshi is an IP Counsel Leader at Thermo Fisher Scientific, specializing in strategic patent dispute resolution, risk management and prosecution, with a focus on AIA patent challenges at the PTAB.  Ashita obtained a Ph.D. in Molecular Biology at Tufts University and a J.D. from the University of California at Berkeley.  She has successfully challenged about 20 patents asserted in four litigations through inter partes and ex parte reexamination, and five patents asserted in three litigations through inter partes review.  She has extensive in-house experience in litigation support, freedom-to-operate analysis, strategic product design and clearance, patent drafting and prosecution.  Her prior law firm experience includes providing non-infringement and invalidity opinions, freedom-to-operate assessments and patent landscaping; drafting and prosecuting applications; and supporting interferences, oppositions and litigations.

    Emily Johnson

    Head of IP Policy & Advocacy

    Amgen, Inc.

    Emily Johnson is Senior Counsel, IP Litigation at Amgen, one of the world’s most innovative biotechnology companies. Emily oversees Amgen’s U.S. and foreign patent litigations and post-grant proceedings before the Patent Trial and Appeal Board and she provides counsel regarding Amgen’s intellectual property strategies.  Before joining Amgen, she represented clients in private practice, litigating nearly 100 intellectual property disputes in both judicial and administrative tribunals.  Emily had the privilege of clerking for the Honorable Arthur Gajarsa at the Federal Circuit.  Emily co-chairs the PTAB Committee of the Federal Circuit Bar Association and chairs the U.S. Post-Grant Patent Office Practice Committee of Intellectual Property Owners Association.

    Philip Johnson

    Chair, Steering Committee

    Coalition for 21st Century Patent Reform

    Phil Johnson is retired as Senior Vice President – Intellectual Property Policy & Strategy of Johnson & Johnson – Law Department. Prior to April of 2014, he was Senior Vice President and Chief Intellectual Property Counsel of Johnson & Johnson where he managed a worldwide group of about 270 IP professionals, of whom over 100 were patent and trademark attorneys. Before joining Johnson & Johnson in 2000, Phil was a senior partner and co-chair of IP litigation at Woodcock Washburn in Philadelphia. During his 27 years in private practice, Phil counseled independent inventors, startups, universities and businesses of all sizes in all aspects of intellectual property law. His diverse practice pertained to advances in a wide variety of technologies, including pharmaceuticals, diagnostics, medical devices, consumer products, semi-conductor fabrication, automated manufacturing, materials and waste management. During his time in private practice, Phil served as trial counsel in countless IP disputes, including cases resolved by arbitration, bench trials, jury trials and appeals to the Federal Circuit Court of Appeals, many of which resulted in reported decisions.

    Todd Walters

    Shareholder

    Buchanan Ingersoll & Rooney PC

    Todd Walters is the Chair of the firm’s Patent Office Litigation practice and Co-Chair of the Intellectual Property section. He is a current Vice-Chair of the Post-Grant Practice Committee of the Intellectual Property Owners Association (IPO), a past Chair of the Patent Trial and Appeal Board (PTAB) Trial Committee of the American Intellectual Property Law Association (AIPLA) and a past Chair of the USPTO Post Grant and Inter Partes Practice Committee of the American Bar Association-Intellectual Property Law (ABA-IPL) section. Todd was named the Best Lawyers ® 2020 Patent Law “Lawyer of the Year” in Washington, D.C. 

  • Contains 5 Component(s), Includes Credits Includes a Live Web Event on 12/01/2022 at 2:00 PM (EST)

    Our panel of distinguished inhouse counsel, Larry Coury, Stephanie Donahue, Henry Hadad, and Stuart Watt, moderated by experienced trial counsel, Paul Berghoff, will guide us through the issues and arguments concerning the current state of enablement and written description law and where the law may be headed.

    For the first time since the founding of the Federal Circuit, the Supreme Court will be taking a close look at Section 112.  The Supreme Court has granted certiorari in Amgen v. Sanofi on the following question: Whether enablement is governed by the statutory requirement that the specification teach those skilled in the art to “make and use” the claimed invention, 35 U.S.C. §112, or whether it must instead enable those skilled in the art “to reach the full scope of claimed embodiments” without undue experimentation—i.e., to cumulatively identify and make all or nearly all embodiments of the invention without substantial “time and effort.” And while the Supreme Court denied certiorari in a closely watched written description case, Juno v. Kite, the law of written description could very well be affected by what the Supreme Court does in Amgen. Our panel of distinguished inhouse counsel, Larry Coury, Stephanie Donahue, Henry Hadad, and Stuart Watt, moderated by experienced trial counsel, Paul Berghoff, will guide us through the issues and arguments concerning the current state of enablement and written description law and where the law may be headed.

    Paul Berghoff

    Founder

    McDonnell Boehnen Hulbert & Berghoff LLP

    Paul Berghoff, founder of McDonnell Boehnen Hulbert Berghoff LLP, has three decades of experience as lead trial counsel in complex patent litigation – both jury and bench trials and PTAB proceedings – concentrating in litigation involving pharmaceuticals, medical devices, biotechnology, electronics, and software. He has successfully tried scores of patent cases and has successfully argued dozens of times before he US Court of Appeals for the Federal Circuit. He services as Chair of the firm’s Litigation & Appeals Practice Group.  He is Vice-Chair of IPO’s Amicus Brief Committee.

    Larry Coury

    Vice President, Head of Litigation and Associate General Counsel

    Regeneron Pharmaceuticals, Inc.

    Larry Coury is Vice President, Head of Litigation and Associate General Counsel at Regeneron Pharmaceuticals, Inc. in Tarrytown, NY.  Larry oversees all of Regeneron’s litigation matters, including patent matters, and he is a registered patent attorney.  Prior to joining Regeneron, Larry was in private practice at Fish & Neave, Paul Weiss, and Cravath.  Larry received his Ph.D. in Biophysics from Harvard University, and his J.D. from Fordham Law School. 

    Stephanie Donahue

    Principal Counsel, Global Patent Litigation

    Sanofi

    Stephanie Donahue is global in-house patent litigation counsel at Sanofi. She is responsible for managing patent infringement litigation brought by and against Sanofi around the world. In that role, among other things, she develops and executes strategic patent infringement litigation action plans, negotiates patent infringement settlements, and communicates case developments and litigation risks to senior management.  Prior to joining Sanofi in 2014, Stephanie practiced at various law firms for over 10 years. She was Counsel at Vinson & Elkins LLP and an associate at Fitzpatrick, Cella, Harper & Scinto (now Venable LLP). 

    Henry Hadad

    Senior Vice President, Innovation Law

    Bristol-Meyers Squibb Company

    Henry Hadad is Senior Vice President and Deputy General Counsel at Bristol-Myers Squibb in Princeton, NJ, where he is Chief Intellectual Property Counsel, as well as lead counsel to Research & Early Development. He was also Chief IP Counsel at Schering-Plough Corporation, and held prior roles at Johnson & Johnson and in private practice. Henry is a member of numerous IP organizations, and is a past president of Intellectual Property Owners Association. He holds a B.S. in Biology from Haverford College and a J.D., cum laude, from the American University, Washington College of Law. 

    Stuart Watt

    Vice President, Law & Intellectual Property Officer

    Amgen, Inc.

    Stuart Watt is Vice President of Law and Intellectual Property Officer of Amgen Inc. and leads a group of 45 patent attorneys responsible for patent strategy, filing and prosecution of patent applications in the U.S. and foreign countries, patent litigation, and patent licensing.  Mr. Watt has actively represented Amgen in patent litigation in the U.S. and various countries around the world. He joined Amgen in 1992.  Prior to that time, he was associated with the patent law firm of Richards, Medlock & Andrews (now Sidley & Austin) in Dallas, Texas.  Mr. Watt is a graduate of Brigham Young University (B.S.Ch.E.) and the University of Washington School of Law (J.D.).

  • Contains 5 Component(s), Includes Credits Includes a Live Web Event on 11/30/2022 at 12:30 PM (EST)

    Join speakers from IPO’s Anticounterfeiting & Antipiracy and AI & New Emerging Technologies Committees to hear about developments related to AI and Effective Enforcement. In addition to demystifying the technology, the panel will discuss how AI and machine learning has revolutionized IP enforcement in the online environment—for example through platforms incorporating AI that assist in identifying online sales of counterfeit products. The panel will also provide brand owner, patent practitioner, and legislative perspectives on AI & machine learning.

    Join speakers from IPO’s Anticounterfeiting & Antipiracy and AI & New Emerging Technologies Committees to hear about developments related to AI and Effective Enforcement. Topics to be covered will include: 

    -how rights owners often lack clarity/understanding about AI and ML when embarking on a brand and/or content protection program
    - explaining “how” it works and “why” it is crucial to any technology driven program
    - intelligent “prioritization” of the (millions of) data points that programs typically involve so that rights owners can tackle the most potent threats and allocate resource appropriately)
    - demystifying AI and ML 
    -the legal aspects of AI and ML 
    -common practical challenges (relevance over volume) and practical tips for how to get the most out of an AI/ML driven program.

    Sumon Dasgupta

    Principal

    Jordan IP Law

    Sumon Dasgupta, a principal of Jordan IP Law, is involved in all aspects of patent law, including patent counseling and portfolio management across different countries and jurisdictions. Sumon has worked with a variety of clients, from solo inventors to Fortune 500 Companies. He has experience in patent enforcement, strategic patent portfolio development, trademarks, and  opinions. Sumon has presented on patent law topics for prestigious organizations, such as the Intellectual Property Owners Association (IPO) Practicing Law Institute Webinar (CLE credits earned for attendees). Sumon is an active member of IPO and is a member of the artificial intelligence (AI) and Emerging Technologies Committee. Sumon is a co-lead author of the AI Patents – Best Practices (White Paper), Intellectual Property Owners Association (published February 2022). Sumon practices in all areas of patent law, with an emphasis on preparing and prosecuting patents in the electrical, mechanical, and computer (software and hardware) arts, including neural networks, virtual reality systems, compilers, encryption systems, network systems, cloud-based systems, semiconductor manufacture and design, vehicle based systems, and graphical interfaces. 

    Tim Golder

    Partner

    Allens

    Tim Golder has more than 38 years' experience in intellectual property law. Tim is a highly experienced adviser on copyright, designs, confidential information and trade marks, as well as trade practices issues dealing with misleading and deceptive conduct. He is adept at drafting licensing, distribution and franchising agreements. He also undertakes substantial work in registering and protecting trade marks, designs and domain names. Tim has a substantial litigation practice in the intellectual property field, enforcing the rights of clients including before the Courts.

    Helen Saunders

    VP Product, Brand Protection

    Corsearch

    Helen Saunders has been working in IP protection for the last 14 years. She has a background combining law, technology, and investigations, both online and offline. She is currently VP Product, Brand Protection at Corsearch, and was formerly Chief Product Officer at Incopro, prior to acquisition by Corsearch in June 2021. During her career, Helen has worked in law enforcement, trade associations and the private sector, analysing and investigating a spectrum of online illegal activity. During her career, Helen has developed her technical skills giving her an excellent understanding of internet technologies and the opportunities created for both illegal and legal uses.  She is passionate about using data to understand online and offline challenges and using combined technology and human expertise to solve them. Helen holds a Bachelor’s in Law and a Master's in Computer and Communication Law from Queen Mary, University of London.

    Michael Sweeney

    Director and Senior Legal Counsel

    Corsearch

    Mike Sweeney is Director and Senior Legal Counsel with Corsearch based in London. As an experienced attorney, Mike counsels brands on all aspects of brand and content protection in the digital space, with a particular focus on leveraging data-driven technology to combat counterfeiting. Mike has many years of experience representing major brands in cross-border litigation in both domestic and international Courts.  More recently, Mike has been focused on leading global anti-counterfeiting and anti-piracy programs for major international brands.  

    Kenya Williams

    Trademark Enforcement Counsel

    Thermo Fisher Scientific Inc.

    Kenya L. Williams has been practicing intellectual property law for over a decade and currently serves as Trademark Enforcement Counsel for Thermo Fisher Scientific Inc. At Thermo Fisher, Kenya is responsible for the protection and enforcement of the company’s worldwide trademark portfolio covering its innovative technologies and industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Gibco, and PPD. Kenya also handles copyright and domain name matters and works cross-functionally with colleagues around the world to enforce Thermo Fisher’s intellectual property rights. 

    Prior to joining Thermo Fisher, Kenya was a trademark attorney in the Los Angeles office of Arent Fox, now ArentFox Schiff, where she was responsible for trademark enforcement and counseling in the retail, automotive, and fashion industries.  

  • Contains 4 Component(s), Includes Credits Includes a Live Web Event on 11/29/2022 at 11:00 AM (EST)

    This program covers the common ethics issues that IP attorneys confront on a regular basis. Topics include: • New rules and key opinions • Confidentiality and privilege in IP cases, including issues arising from protective order violations • Duty of loyalty and conflict issues • Duties related to candor to the USPTO and courts • Duties regarding third parties • USPTO OED rule changes and disciplinary decisions

    This program covers the common ethics issues that IP attorneys confront on a regular basis. Topics include:

    • New rules and key opinions
    • Confidentiality and privilege in IP cases, including issues arising from protective order violations
    • Duty of loyalty and conflict issues
    • Duties related to candor to the USPTO and courts
    • Duties regarding third parties
    • USPTO OED rule changes and disciplinary decisions

    Michelle Greer Galloway

    Of Counsel

    Cooley, LLP

    Michelle Greer Galloway has been an associate, partner and is currently of counsel to the Cooley Litigation department and its IP group. She is a patent litigator and if a former chair of the ABA IP Section, Ethics and Professional Responsibility Committee and she received the Recognition of Outstanding Leadership Contribution in 2013. She also served on the California Lawyers Association Litigation Section Executive Committee. In addition to her IP work, Michelle works with companies, teams and individuals on leadership and management skills. In addition to her practice, she is a Lecturer teaching courses in patent litigation and professional development and management skills at Stanford Law School and a lecturer at Santa Clara Law School teaching courses in patent litigation, pre-trial litigation techniques, and law practice management.  She also teaches IP courses at IE University (Spain).

    Eric Prager

    Partner

    Venable, LLP

    Eric A. Prager is a partner in the IP Transactions group of Venable LLP, where he is based in the firm’s New York office.  He has focused his practice on intellectual property matters for more than 25 years, with an emphasis in the advertising, digital media, and software industries.  His work spans all substantive areas of IP law in both contentious and non-contentious engagements.  He is a frequent author and speaker on IP issues.  He has been the national chair of an annual two-day legal program called “Intellectual Property Issues in Business Transactions” (Practising Law Institute), and he co-developed and co-chaired an annual two-day program called “Standard Setting and Patent Pools” (Law Seminars International).  He has also served more than 10 years as Adjunct Professor of Law at Fordham Law School.

  • Contains 5 Component(s), Includes Credits

    This webinar will focus on the history and context of the agencies’ 2013, 2019, and (draft) 2021 policy statements, as well as the legal impact of their withdrawal. It will also include a discussion of where the U.S. government, standards organizations, and private parties should go from here.

    The U.S. Department of Justice, National Institute of Standards and Technology, and Patent and Trademark Office recently withdrew their 2019 Policy Statement on Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments without reinstating their previous 2013 policy statement or issuing a new statement. The agencies took this action despite having circulated a draft policy statement in 2021 that elicited extensive public comment. This webinar will focus on the history and context of the agencies’ 2013, 2019, and (draft) 2021 policy statements, as well as the legal impact of their withdrawal. It will also include a discussion of where the U.S. government, standards organizations, and private parties should go from here. 

    Jorge Contreras

    Director, Program on Intellectual Property and Technology Law

    University of Utah S.J. Quinney College of Law

    Jorge L. Contreras is the James T. Jensen Endowed Professor for Transactional Law and Director of the Program on Intellectual Property and Technology Law at the University of Utah S.J. Quinney College of Law, and will serve as a Visiting Fellow at the London School of Economics and Political Science during 2023. Prior to entering academia, Professor Contreras was a partner at the international law firm Wilmer Cutler Pickering Hale and Dorr LLP where he practiced intellectual property transactional law in Boston, Washington DC and London. Prof. Contreras’s academic research focuses on intellectual property, antitrust law, technical standardization and science policy. He has published more than 150 academic articles and book chapters and has written or edited twelve books including the 2-volume Cambridge Handbook of Technical Standardization Law (NY: Cambridge Univ. Press, 2017, 2019).  His scholarship has received numerous awards and recognition, including, most recently, the Patent & Trademark Office Society’s 2021 Rossman Memorial Award and the University of Utah’s 2020 Distinguished Research Award. Professor Contreras has appeared before the U.S. Senate Subcommittee on Intellectual Property, the Federal Trade Commission and the European Commission, and has served as an expert witness before courts across North America, South America and Europe.  His latest book, The Genome Defense: Inside the Epic Legal Battle to Determine Who Owns Your DNA, was recognized by the NY Times as one of the top eleven nonfiction books of Fall 2021 and selected as the Best Patent Law Book of the Year by the UK-based IPKat blog.  He is an elected member of the American Law Institute and the former co-chair of the National Conference of Lawyers and Scientists.  He received his JD from Harvard Law School, earned his BSEE and BA in English at Rice University and clerked for Chief Justice Thomas R. Philips of the Texas Supreme Court. 

    Nicholas Matich

    Principal

    McKool Smith

    Nicholas Matich is a principal in McKool Smith’s intellectual property (IP) practice, representing a broad array of clients in IP disputes both as plaintiffs and defendants and advising clients on IP strategy.  Nick frequently speaks and is quoted in the media on US IP policy and litigation, and his clients include high tech companies, life science companies, and major trademark holders.  Before joining the firm, Nick served as Acting General Counsel of the United States Patent and Trademark Office (USPTO), where he represented the agency before the Federal Circuit and U.S. Supreme Court.  Since joining McKool, IAM selected Nick as one of the world’s top 300 IP strategists and described him as: “A thoughtful advisor, tenacious advocate, and a brilliant lawyer.” Nick “has a profoundly deep understanding of SEP and FRAND issues, and his insights are critical to positioning his clients for success. He is highly recommended to any IP holder looking to get the most out of their assets.” Lawdragon has also recognized Nick in their inaugural Guide to the 500 Leading Litigators in America.

    Stevan Mitchell

    Director

    Office of Standards and Intellectual Property (OSIP), International Trade Administration

    Stevan D. Mitchell is the Director of the International Trade Administration’s Office of Standards and Intellectual Property (OSIP) at the U.S. Department of Commerce. OSIP promotes foreign market opportunities for export of U.S. products and services through advancements in standards and intellectual property trade policy and by promoting business awareness. The office provides direct assistance to companies seeking to protect and enforce intellectual property rights (IPR) in foreign markets, including through the STOPfakes.gov Roadshow program and website. Previously Mr. Mitchell served as Vice President, Intellectual Property Policy for the Entertainment Software Association (ESA). Mr. Mitchell also served as Senior Counsel to the Computer Crime and Intellectual Property Section (CCIPS) of the U.S. Department of Justice (DOJ), and served as a Member of the President's Commission on Critical Infrastructure Protection (PCCIP). Mr. Mitchell earned his law degree from the Florida State University College of Law, where he served as Editor-in-Chief of the Law Review. After completing a clerkship in the United States District Court for the Southern District of Florida, he joined the Criminal Division of the Department of Justice through its Honor Graduate Program.

    Paul Zeineddin

    Partner

    Blank Rome, LLP

    Paul Zeineddin is Blank Rome’s Co-chair of Patent Litigation and a lead counsel with over 60 patent infringement cases in U.S. district courts and the U.S. International Trade Commission (“ITC”).  Paul’s practice focuses on patent litigation in the communications, semiconductor, software, and consumer electronic industries and the complex issues arising related standard essential patents (“SEPs”) and their FRAND commitments. He has represented clients in the United Nations as well as various international standard-setting organizations on SEPs and FRAND issues. Paul has served as the lead negotiator in large global licensing deals relating to SEPs and in the formation of several patent pools. He has also worked closely with his clients as European and Asian counsel on global FRAND disputes. Paul has a BS and an MS in electrical engineering. Before embarking on his legal career, Paul served as a senior telecommunications engineer in British Telecom and the MITRE Corporation. He also previously served as senior IP counsel at Samsung Electronics.

  • Contains 5 Component(s), Includes Credits

    In this webinar, the panel will discuss the basics around what the myth of the meritocracy is and how it affects the legal profession. The panel will be using the published white paper as our guide.

    The legal profession has long been plagued by the myth of meritocracy. Traditional merit-based hiring practices exclude candidates that could not pay for or get admitted to a top-tier law school as well as candidates that are not similar in background to the decision makers in law firms and corporate legal departments. In recent years, law firms and corporate legal departments have revamped, or tried to revamp, their diversity and inclusion initiatives. Active ongoing discussions are trending on advantages of a diverse workforce and ways to hire and retain diverse candidates. However, many diversity & inclusion initiatives seem to fail to address the myth of the meritocracy, which is a core issue still silently plaguing D&I efforts within law firms and corporate legal departments.

    In this webinar, the panelists will discuss the basics around what the myth of the meritocracy is and how it affects the legal profession along with some practical tips on addressing the myth of the meritocracy. The panelists will be using the published white paper as their guide.

    This webinar is sponsored by Banner Witcoff, Boult Wade Tennant LLP and Fletcher Yoder

    Shruti Costales

    Senior Legal Counsel, OEM Software Procurement

    Dell Technologies

    Shruti Costales is currently OEM Software Procurement Senior Legal Counsel at Dell Technologies. Prior to joining Dell Technologies, she was Senior Counsel at another Fortune 100 corporation where she was responsible for all 3D printing materials related commercial transactions, Intellectual Property (IP) transactions, and patent portfolios. Shruti is a licensed patent attorney with almost 20 years of legal experience working in private practice, in-house, and with the Federal Government. She has experience working on various IP matters, litigations, transactions, due diligence assessments, and procurement matters. Shruti earned her Bachelor of Science in Chemical Engineering from Purdue University and her Juris Doctor from the University of New Hampshire School of Law. She is the Co-Chair for the Speakers Subcommittee for Dell’s Pro Bono Committee and she is also the Chair of the Diversity & Inclusion Committee for the Intellectual Property Owners Association where she has co-authored many white papers and guides. 

    Susi Fish

    Partner

    Boult Wade Tennant

    Susi Fish is a Chartered Patent Attorney and European Patent Attorney in the High Tech and Electrical Group of Boult Wade Tennant. Susi works across a range of technologies; mainly focused on biomedical engineering, medical physics and aerospace related matters. However, Susi has additional experience working in the fields of design, manufacture and testing of mechanical systems. She also involves colleagues with expertise in other specialties where more appropriate for particular matters. As well as prosecuting patent applications before the UKIPO and EPO, Susi has also had significant successes in opposition and appeal work before the EPO. Susi is an active supporter of IP Inclusive, and serves as co-chair for the Women in IP group. She also sits on the Diversity and Inclusion and Women in IP committees of the Intellectual Property Owners Association (IPO). Susi is a member of the American Intellectual Property Law Association (AIPLA) and sits on their Women in IP and IP Practice in Europe committee. She spoke on diversity and inclusion matters at the IQPC Global IP Exchange. She is a co-author on a couple of whitepapers issued by the IPO; one entitled “Diversity in the European Innovation Industry and IP profession” and the other entitled “The myth of the meritocracy in law firms and corporate legal departments“.

    Mercedes Meyer

    Attorney

    Banner & Witcoff, Ltd.

    Mercedes K. Meyer, Ph.D., draws on her doctorate in virology and degree in chemistry to apply a deep understanding of complex biotechnology and scientific research in advising life science clients on commercializing and protecting product innovations as well as performing diligence for investing in new technologies. She oversees global patent portfolio development, patent portfolio due diligence and war games, strategy and management on behalf of clients and counsels on innovation monetization. Mercedes maintains an extensive biotechnology and pharmaceutical patent management and prosecution practice, particularly in corporate joint development projects. Mercedes also advises and speaks frequently on patent ethics.

    Priya Subramony

    Senior Patent Agent at Thermo Fisher Scientific

    Thermo Fisher Scientific

    Priya Subramony is an experienced IP professional with 23+ years of U.S. patent prosecution as well as in-house expertise in handling large cross-business patent portfolios across many jurisdictions, working with clients in innovation sensing, capture, competitor intelligence, IP due diligence, product clearance and in- and out- licensing in biotechnology and other mechanical art areas.

    Jim Thomas

    Shareholder

    Fletcher Yoder

    Jim Thomas joined Fletcher Yoder in November 2011. His areas of technological familiarity include electrical power systems, control systems, semiconductor fabrication and design, computer hardware and software, telecommunications, database management, seismic data processing, and a wide variety of other electrical and mechanical arts.

  • Contains 5 Component(s), Includes Credits

    This webinar will focus on the Unified Patent Court and how it will change the way businesses operate in this new world. Join our expert panel—Bettina Wanner of Bayer Intellectual Property GmbH, Boris Kreye of Bird & Bird LLP, and Jakob Kellenberger of Procter & Gamble Services Co. NV—to learn more about the UPC.

    March/April of 2023 will see the start of the new Unitary Patent System in Europe. The system is made up of the newly-established Unified Patent Court (UPC) and the Unitary Patent. The Unitary Patent System represents a seismic shift in the European Patent landscape. Especially the UPC will have a great impact on the patent litigation landscape and thereby the business landscape in Europe. This webinar will focus on the Unified Patent Court and how it will change the way businesses operate in this new world. Join our expert panel—Bettina Wanner of Bayer Intellectual Property GmbH, Boris Kreye of Bird & Bird LLP, and Jakob Kellenberger of Procter & Gamble Services Co. NV—to learn more about the UPC.

    This webinar is sponsored by Bird & Bird LLP

    Jakob Kellenberger

    Senior Director and Associate General Counsel

    Procter & Gamble

    Jakob Kellenberger is a Senior Director and Associate General Counsel for Procter & Gamble in Belgium. In this position, Mr. Kellenberger is responsible for P&G’s Global Home Care- and European Fabric Care-IP. He oversees a group of Patent Professionals located in P&G’s Newcastle and Brussels Innovation Centers and advises Procter & Gamble’s senior management on intellectual property issues. Mr. Kellenberger has authored numerous P&G patents and patent applications, has led a number of oppositions/appeals and hearings in the EPO, has been involved in license agreements, acquisitions and divestitures, in mediation and in IP litigation. Mr. Kellenberger holds a MSc with a focus on Molecular Biology from the Swiss Federal Institute of Technology (Eidg. Tech. Hochschule - ETH) in Zürich and a Postgraduate degree in IP law from the same school. He is a Qualified Representative before the EPO, and has over 25 years of experience in IP.

    Boris Kreye

    Partner

    Bird & Bird LLP

    Boris Kreye is a partner in Bird & Bird, LLP's IP practice group in Munich and head of the litigation team there. As a litigator, he obtained extensive experience in leading and handling multi-jurisdictional patent disputes over the years and decades. He represents national and international clients both on the offensive and the defensive side. He appears before all German patent infringement courts, the Federal Patent Court in Munich and the European Patent Office (EPO) and has particular expertise in coordinating international patent disputes in multiple countries, both for plaintiffs and defendants.

    Over the years he has been involved in several high-profile cases, areas of expertise including life sciences, consumer electronics mobile communications, SEP and FRAND, automotive and nano-technology. He has represented leading companies from the US, Japan and Europe in these industries. He also represents clients in oppositions and nullity proceedings before the EPO, the German Patent and Trade Mark Office, the Federal Patent Court and the Federal Supreme Court. Furthermore, he is listed as a WIPO arbitrator. Besides advising clients in all other IP matters, particularly in trademarks, unfair competition law and design rights, he also has experience in assisting and representing clients in ICC arbitration proceedings and evidence proceedings under the Hague Convention (mostly in connection with the US litigation).

    Dr. Bettina Wanner

    Head IP Advocacy & Strategy

    Bayer Intellectual Property GmbH

    Dr. Bettina Wanner is Head of IP Advocacy and Strategy for Bayer Intellectual Property GmbH. She is also Chair of IPO's European Practice Committee.

  • Contains 2 Component(s)

    The webinar will discuss real stories about challenges in leadership and advancement and consider hypotheticals on how panelists would respond to specific challenging fact patterns. This will include discussion about how changes in leadership styles can make a positive impact on those who continue to be negatively impacted in a post-2020 world, including discussing mental burdens, lack of barrier between work and home, the downsides of “flexibility,” other inequities, and leading across generations.

    This webinar will discuss real stories about challenges in leadership and advancement and consider hypotheticals on how panelists would respond to specific challenging fact patterns. This will include discussion about how changes in leadership styles can make a positive impact on those who continue to be negatively impacted in a post-2020 world, including discussing mental burdens, lack of barrier between work and home, the downsides of “flexibility,” other inequities, and leading across generations.

    *Please note that there will be no CLE credit offered for this program.*

    Carlyn Burton

    Partner

    Osha Bergman Watanabe & Burton LLP

    Carlyn Burton uses intellectual property (IP) in creative and strategic ways to help clients achieve their business goals.  With more than 15 years of IP legal experience under her belt, Ms. Burton has represented a wide range of clients – from accomplished Fortune 500 companies to innovative start-ups.  As a scientist, she combines diverse technical knowledge with a strong skill set across multiple areas:  domestic and foreign patent prosecution and maintenance, IP counseling, licensing, and IP litigation in the fields of chemistry, materials science, and mechanical engineering, with an emphasis in oilfield technologies, specialty chemicals, polymers, nanotechnology, and pharmaceuticals.

    Gaby Longsworth

    Director

    Sterne Kessler Goldstein & Fox

    Gaby L. Longsworth, Ph.D., is a director in Sterne Kessler's Biotechnology & Chemical Practice Group and chair of the firm's Diversity & Inclusion Committee. Gaby has been consistently recognized as a “Life Sciences Star” by LMG Life Sciences since 2016. In 2017 and 2020, she was a finalist for "Patent Strategy and Management Attorney of the Year, District of Columbia," in LMG's annual Life Sciences Awards. In 2019, Profiles in Diversity Journal listed her among their “Women Worth Watching®” award.

    Gaby is particularly well-known by innovator and generic pharmaceutical companies world-wide for her insights and knowledge of intellectual property and Hatch-Waxman law. Capitalizing on her extensive generic pharmaceutical expertise, Gaby is uniquely qualified to evaluate complex innovator IP portfolios from a generic perspective, including method-of-use claim coverage relative to the product label, Orange Book patent listing and data exclusivity, 505(b)(2) strategies, labeling carve-outs, and Patent Term Extensions.

    Gaby also counsels biopharmaceutical clients from around the world in all areas of patent procurement, including domestic and foreign patent preparation and lifecycle management strategies. Gaby practices primarily in the fields of biotherapeutics, small molecules, biologics, immunotherapy, antibody technologies, microbiome-based technologies, probiotics, synthetic biology, DNA amplification/PCR, diagnostics, vaccines, viral vectors, formulations and drug delivery.

    Gaby has rendered more than a thousand invalidity, non-infringement, freedom-to-operate, and patentability opinions in areas such as: small molecules; polymorphs; crystal forms and salts; chemical synthesis; agricultural chemicals, pharmaceutical formulations, including oral dosage forms and parenterals; transdermal patches; ophthalmics, creams, gels, suspensions, nasal and oral inhalation forms, pharmacokinetics, nucleic acids, medical devices and therapeutic antibodies.

    In addition, Gaby has strong experience in biopharmaceutical Inter Partes Review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB). 

    In addition to maintaining a vibrant practice, Gaby is one of the organizers of “INSPIRED by the Women of Sterne Kessler," an affinity group designed to engage female attorneys through participation in a variety of programs that support personal and professional development. She is also a sustaining member of the Women’s Bar Association of the District of Columbia.

    Gaby earned a J.D. at Georgetown University Law Center, a Ph.D. in human genetics and molecular biology at The Johns Hopkins University and a B.S. in molecular biology from the Florida Institute of Technology. She is fluent in Dutch.

    Gillian Thackray

    Vice President, Chief Counsel for IP

    Thermo Fisher Scientific

    Gillian Thackray is an award-winning lawyer and expert legal and business strategist. Her multi-faceted approach integrates law, business, and practicality to help business partners reach their goals. Her specialties include: Business Strategy, Litigation and Dispute Resolution, Commercial Advice, Complex Transactions, Business Negotiations, Licensing, Risk Mitigation, New Product Development, Intellectual Property Strategy, Technology, Regulatory Compliance, and Legal operations. 

    Richard Watkins

    Sr. Principal Legal Counsel

    Medtronic

    Richard Watkins is a senior principal legal counsel at Medtronic and has practiced IP Law for 20 years. He holds a BS in Chemistry from Morehouse College and a law degree from Georgetown University. Prior to Medtronic, Richard spent time in private practice and corporate in house positions in Philadelphia, Chicago, and Memphis. He has been active in the IPO Diversity and Inclusion committee and is currently serving as the Co-Chair of the Black IP Professionals in IPO.

     

  • Contains 5 Component(s), Includes Credits

    There is no question that the legal field remains one of the least diverse professions in the United States. Not only are men overrepresented in the practice of law, but they outnumber women in equity partner positions nearly five to one. The statistics become even grimmer when we examine patent attorneys, who need both a law degree and a hard science degree. In the wake of a new study indicating that the Mansfield Rule is not as effective as thought for increasing diversity, what is our industry to do? Join our distinguished panelists who have taken action to help diversity the patent bar. Learn about their innovative and collaborative programs and how you can get involved to be part of the solution.

    There is no question that the legal field remains one of the least diverse professions in the United States.  Not only are men overrepresented in the practice of law, but they outnumber women in equity partner positions nearly five to one.  The statistics become even grimmer when we examine patent attorneys, who need both a law degree and a hard science degree.  In the wake of a new study indicating that the Mansfield Rule is not as effective as thought for increasing diversity, what is our industry to do?  Join our distinguished panelists who have taken action to help diversity the patent bar.  Learn about their innovative and collaborative programs and how you can get involved to be part of the solution.

    This webinar is sponsored by Harrity & Harrity, LLP and Patent Quality Education & Training Foundation

    Michelle Bugbee

    Senior Counsel

    Eastman Chemical Company

    Michelle Bugbee is a Senior Counsel in the Intellectual Property group of Eastman Chemical Company in the Springfield, MA office supporting the Advanced Interlayers business.  Michelle has over 20 years of patent experience in the chemical industry and with sporting goods.  Prior to attending law school, Michelle worked for over ten years in various engineering and supervisory roles.  Michelle is currently a co-chair of the IPO Women in IP committee as well as a co-chair of the Women Inventors subcommittee of the Women in IP committee and assisted in the development of IPO’s Gender Diversity in Innovation Toolkit (launched in September 2019).  

    Braxton K. Davis

    Executive Director

    National Council on Patent Practicum

    Prior to obtaining his J.D. from Georgia State, Braxton Davis earned undergraduate degrees in physics and electrical engineering from Morehouse College and Georgia Institute of Technology, respectively. After obtaining his J.D., Braxton began his career in patent law working with the AT&T Intellectual Property Patent Development and Innovation Team, and was later named partner at Amin, Turocy, and Watson patent law firm. He now serves as in-house counsel at Facebook.

    Davis founded the Patent Institute of Training, which teaches promising engineers how to be successful patent agents and attorneys. Davis also established the National Council on Patent Practicum, a nonprofit that focuses on increasing quality within the patent profession via a certification program and increasing the number of women and minority patent practitioners within the profession. Additionally, Davis founded a tech startup Metric Mate, a mobile platform for tracking workouts and performance data in the fitness space.

    Ayana Marshall

    Patent Data Analyst & Chair of Patent Pathways

    Harrity & Harrity, LLP

    Ayana Marshall is a Trinidad and Tobago born patent data analyst who has 11+ years experience in the patent field. She has a Ph.D. in Biomedical Engineering and a Masters of Science in Electrical Engineering. At Harrity & Harrity, she serves as a Patent Data Analyst, Chair of the Patent Pathways subcommittee, and is a member of the Diversity Committee. She is also a member of the Intellectual Property Owners Association’s (IPO) Diversity & Inclusion Committee as well as the association’s Outreach Committee. She is very passionate about increasing the number of underrepresented minorities in the patent field. Ayana enjoys cooking and baking for her family of six, her husband, two sons, and two pups.

    Tim Wilson

    President

    Patent Quality Education & Training Foundation

    Tim Wilson is Director of Patents in the Legal Division at SAS Institute Inc., the world’s largest private software company, where he leads the patent practice.  He also provides advice on all types of intellectual property law matters and competitive intelligence issues. Prior to joining SAS, Tim was an associate at Brown Raysman in New York, where he advised clients on all manner of licensing and outsourcing transactions.  Tim began his legal career as a patent and intellectual property litigator with Jones Day in Cleveland.  Tim received his JD from Syracuse University College of Law in 1992 and a BS from Pennsylvania State University in 1989. Tim is a member of the Editorial Board of Intellectual Property Magazine.

  • Contains 7 Component(s), Includes Credits

    Join IPO to hear from the USPTO and WIPO on the implementation of the World Intellectual Property Office (WIPO) Standard ST.26 as the experts discuss the changes to sequence listings filed in patent applications that contain disclosures of nucleotide and/or amino acid sequences. WIPO Standard ST.26, requiring XML formatting, went into effect worldwide on July 1, 2022. The USPTO has adopted new rules to implement this Standard as published at 87 Fed Reg. 30806, (May 20, 2022). The presentation will provide guidance on how you will be able to prepare and submit a compliant sequence listing in U.S. patent applications and PCT applications filed on or after July 1, 2022.

    Join IPO to hear from the USPTO and WIPO on the implementation of the World Intellectual Property Office (WIPO) Standard ST.26 as the experts discuss the changes to sequence listings filed in patent applications that contain disclosures of nucleotide and/or amino acid sequences. WIPO Standard ST.26, requiring XML formatting, went into effect worldwide on July 1, 2022. The USPTO has adopted new rules to implement this Standard as published at 87 Fed Reg. 30806, (May 20, 2022). 

    Updates to PCT rules and practice have been implemented to address submission of sequence listings in XML format for PCT applications filed beginning on July 1, 2022. During the webinar, USPTO and WIPO legal and technical experts will present an overview of implementation of WIPO Standard ST.26 at the USPTO for applications filed with USPTO and WIPO for PCT applications. 

    The presentation will provide guidance on how you will be able to prepare and submit a compliant sequence listing in U.S. patent applications and PCT applications filed on or after July 1, 2022.

    Anish Gupta

    PCT Legal Examiner-International Patent Legal Administration

    USPTO

    Anish Gupta has been a PCT Legal Examiner within the International Patent Legal Administration at the United States Patent and Trademark Office since 2013.   As a Legal Examiner, Anish assists in matters relating to international applications filed under the Patent Cooperation Treaty and national applications filed under 35 U.S.C. 371.  Since joining International Patent Legal Administration, he has been a member of the USPTO ST.26 Task Force group and has been involved with the drafting and implementation of Standard ST.26 and its annexes.  Anish has also assisted in the development of the Federal Rules that implemented ST.26 for U.S. applications. Prior to the joining International Patent Legal Administration, Anish was a primary patent examiner in the biotechnology group at the USPTO.  As a patent Examiner, he examined biotechnology patent applications focusing on peptide/protein subject matter. Anish holds a Juris Doctorate from The American University, Washington College of Law and a B.S. in Chemistry from the University of Pittsburgh.    

    Wayne Jaeschke

    Assistant General Counsel - Patents

    Johnson & Johnson

    Hanna Kang

    Legal Officer, PCT Legal and User Relations Division

    World Intellectual Property Organization

    Hanna Kang works as Legal Officer in the PCT Legal and User Relations Division of the World Intellectual Property Organization (WIPO) in Geneva, Switzerland. In her role, Hanna helps draft and implement changes to the PCT legal framework, offers training courses and advises users on PCT procedures. A national of the United States of America, Hanna joined WIPO in 2013 and worked as Associate Legal Officer in the WIPO Arbitration and Mediation Center prior to joining the PCT Legal and User Relations Division.  Prior to studying law, Hanna worked in biotechnology. She is a member of the State Bar of California and licensed before the USPTO.

    Mary Till

    Senior Legal Advisor in the Office of Patent Legal Administration (OPLA)

    USPTO

    Mary C. Till is a Senior Legal Advisor in the Office of Patent Legal Administration (OPLA) at the USPTO.  She focuses on administration of the Patent Term Restoration provisions of the Hatch-Waxman Act on behalf of the USPTO. Additionally, she is involved with specialty projects including reexamination, reissue and training to the examining corps and the public on relevant case law, such as subject matter eligibility.  Most recently, she has been involved with various projects associated with provisions of the America Invents Act.  Prior to joining OPLA, she worked in private practice at Foley & Lardner in Washington, DC.  In private practice, Ms. Till was actively engaged in procuring patent protection for various life science corporations and several universities, counseling the entities regarding product launches and providing opinions of counsel on freedom to operate, validity, infringement, invalidity and due diligence issues.  She also was a patent examiner from 1993 until 1997, when she joined Foley & Lardner. She earned her J.D. from American University’s Washington College of Law, cum laude. She received a B.S. in Chemistry from Gannon University and her M.S. in Organic Chemistry from Virginia Tech.  She is admitted to the bar of Virginia and to practice before the United States Patent and Trademark Office.